|
|
|
Insider
Information: |
Geraghty James A |
Relationship: |
|
City: |
Framingham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
311,097 |
|
Indirect Shares
|
138 |
|
|
Direct
Value |
$678,415 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
311,235 |
|
|
Total
Value |
$678,415 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
GTC Biotherapeutics Inc |
GTCB |
Director |
2009-12-31 |
19,025 |
2009-12-31 |
138 |
Premium* |
|
Genzyme Corp |
GENZ |
Senior Vice President |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
2021-01-04 |
104,770 |
2013-08-19 |
0 |
Premium* |
|
Juniper Pharmaceuticals Inc |
JNP |
Director |
2018-08-14 |
0 |
2015-05-26 |
0 |
Premium* |
|
Voyager Therapeutics, Inc. |
VYGR |
Director |
2018-09-10 |
76,588 |
|
0 |
Premium* |
|
Pieris Pharmaceuticals, Inc. |
PIRS |
|
2018-05-15 |
20,000 |
2017-08-17 |
0 |
Premium* |
|
Fulcrum Therapeutics, Inc. |
FULC |
Director |
2021-06-28 |
90,714 |
|
0 |
Premium* |
|
Orchard Therapeutics Plc |
ORTX |
|
2024-01-24 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACGN |
Aceragen, Inc |
Director |
|
2021-01-04 |
4 |
A |
$4.02 |
$19,501 |
D/D |
4,851 |
104,770 |
0 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2005-03-14 |
4 |
B |
$1.75 |
$8,750 |
D/D |
5,000 |
56,791 |
2.39 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2005-05-16 |
4 |
B |
$1.32 |
$3,960 |
D/D |
3,000 |
59,791 |
2.31 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2005-11-11 |
4 |
B |
$1.59 |
$4,840 |
D/D |
3,000 |
62,791 |
2.31 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2006-09-29 |
4 |
B |
$1.24 |
$3,250 |
D/D |
2,621 |
65,412 |
2.31 |
- |
|
GTCB |
GTC Biotherapeutics Inc |
Director |
|
2007-12-14 |
4 |
B |
$0.87 |
$8,696 |
D/D |
10,000 |
83,785 |
2.39 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2013-08-19 |
4 |
B |
$1.75 |
$525,000 |
D/D |
300,000 |
300,000 |
2.39 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2013-09-16 |
4 |
B |
$1.90 |
$114,000 |
D/D |
60,000 |
360,000 |
2.39 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2013-12-06 |
4 |
B |
$2.72 |
$108,800 |
D/D |
40,000 |
400,000 |
2.39 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2014-05-27 |
4 |
B |
$2.65 |
$26,500 |
D/D |
10,000 |
412,649 |
2.39 |
- |
|
JNP |
Juniper Pharmaceuticals I... |
Director |
|
2015-06-01 |
4 |
B |
$8.38 |
$172,209 |
D/D |
20,550 |
0 |
2.39 |
- |
|
JNP |
Juniper Pharmaceuticals I... |
Director |
|
2015-08-06 |
4 |
B |
$10.46 |
$125,520 |
D/D |
12,000 |
33,011 |
2.39 |
- |
|
JNP |
Juniper Pharmaceuticals I... |
Director |
|
2015-11-17 |
4 |
B |
$11.75 |
$94,000 |
D/D |
8,000 |
43,079 |
2.39 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2016-05-13 |
4 |
B |
$1.34 |
$13,400 |
D/D |
10,000 |
425,649 |
2.39 |
- |
|
JNP |
Juniper Pharmaceuticals I... |
Director |
|
2016-08-22 |
4 |
B |
$5.90 |
$23,972 |
D/D |
4,063 |
58,216 |
2.39 |
- |
|
JNP |
Juniper Pharmaceuticals I... |
Director |
|
2016-08-23 |
4 |
B |
$6.03 |
$17,716 |
D/D |
2,937 |
61,153 |
2.39 |
- |
|
JNP |
Juniper Pharmaceuticals I... |
Director |
|
2016-09-13 |
4 |
B |
$5.97 |
$11,930 |
D/D |
2,000 |
63,153 |
2.39 |
- |
|
JNP |
Juniper Pharmaceuticals I... |
Director |
|
2017-03-17 |
4 |
B |
$4.82 |
$9,637 |
D/D |
2,000 |
65,153 |
2.39 |
- |
|
PIRS |
Pieris Pharmaceuticals, I... |
Director |
|
2017-08-17 |
4 |
B |
$4.82 |
$48,200 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
PIRS |
Pieris Pharmaceuticals, I... |
|
|
2018-05-15 |
4 |
B |
$5.75 |
$57,500 |
D/D |
10,000 |
20,000 |
0.01 |
- |
|
ACGN |
Aceragen, Inc |
Director |
|
2018-08-07 |
4 |
B |
$5.58 |
$55,800 |
D/D |
10,000 |
65,433 |
2.39 |
- |
|
VYGR |
Voyager Therapeutics, Inc... |
Director |
|
2018-08-17 |
4 |
B |
$18.31 |
$54,930 |
D/D |
3,000 |
73,588 |
2.39 |
- |
|
VYGR |
Voyager Therapeutics, Inc... |
Director |
|
2018-09-10 |
4 |
B |
$19.39 |
$58,170 |
D/D |
3,000 |
76,588 |
2.39 |
- |
|
FULC |
Fulcrum Therapeutics, Inc... |
Director |
|
2021-06-28 |
4 |
B |
$9.16 |
$91,600 |
D/D |
10,000 |
90,714 |
2.39 |
- |
|
GENZ |
Genzyme Corp |
Senior Vice President |
|
2011-04-04 |
4 |
D |
$74.00 |
$8,288 |
I/I |
(112) |
0 |
0 |
- |
|
65 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|